Abstract

As medical cyclotrons are becoming more abundant, 123I and 124I are getting more attention as alternatives to 131I for diagnostics of thyroid disease. Both 123I and 124I provide better diagnostics, deliver less dose to patients and both reduce the risk of thyroid stunning, facilitating subsequent therapy. Dry distillation of radioiodine from tellurium dioxide targets has become the standard approach to producing these radioiodines. Setting up such a production of radioiodine is associated with a lengthy optimization of the process and for this purpose natural tellurium is often used for economical reasons. In this paper, the distillation parameters are scrutinized to ensure optimal distillation temperature, in order to minimize time spent and prevent loss of expensive target material. It is further demonstrated how the individual iodine isotopes, produced from proton bombardment of natTe, will diffuse out of the target in a time dependent ratio. We believe the effect is due to the isotopes having their maximum cross section at different energies. The individual isotopes produced will thus have their highest concentration at different depths in the target. This results in individual mean diffusion lengths and diffusion times for the different isotopes.

Highlights

  • Due to the increasing number of medical cyclotrons and the growing demand for more specialized radio tracers, an increasing number of sites are producing radioiodine, namely 123I and 124I

  • Since 123I has no β component, it delivers significantly less dose to the thyroid tissue. This minimizes the risk of thyroid stunning, a phenomenon rendering the thyroid tissue unable to take up iodine, and complicates subsequent radiotherapy [2,3]. 124I (T1⁄2 = 4.18 days) has its own merits as a radionuclide for diagnostics

  • We began by examining the distillation profile for different distillation temperatures

Read more

Summary

Introduction

Due to the increasing number of medical cyclotrons and the growing demand for more specialized radio tracers, an increasing number of sites are producing radioiodine, namely 123I and 124I. Since 123I has no β component, it delivers significantly less dose to the thyroid tissue. This minimizes the risk of thyroid stunning, a phenomenon rendering the thyroid tissue unable to take up iodine, and complicates subsequent radiotherapy [2,3]. There are several advantages to this approach Both 123Te(p,n)123I and 124Te(p,n)124I have maximum cross sections below 14 MeV [8], which is within reach of many medical cyclotrons, and only a general solid target setup is needed. This paper summarizes the findings from research carried out at Herlev

Targetry nat
Bombardment
Dry Distillation
Results and Discussion
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call